Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Berry

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Investigative Dermatology|January 28, 2014
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signalingJeffrey D McBride, Alicia J Jenkins, Xiaochen Liu, et al.
ACS Nano|February 13, 2023
Multifunctional Microgel-Based Cream Hydrogels for Postoperative Abdominal Adhesion PreventionBo Liu, Yunfan Kong, Olawale A Alimi, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Oncotarget|May 8, 2015
Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesNaushad Ali, Parthasarathy Chandrakesan, Charles B Nguyen, et al.
Cancers|January 10, 2026
BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung CancerRebaz Ahmed, Ranganayaki Muralidharan, Narsireddy Amreddy, et al.
Plos One|November 22, 2013
Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanismNaushad Ali, Heba Allam, Ted Bader, et al.
International Journal of Cancer|March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Oncotarget|January 22, 2015
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaNathaniel Weygant, Dongfeng Qu, Randal May, et al.
British Journal of Cancer|May 27, 2020
The role of sex in the innate and adaptive immune environment of metastatic colorectal cancerAnita L Ray, Robert A Nofchissey, Maaz A Khan, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|January 28, 2014
Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signalingJeffrey D McBride, Alicia J Jenkins, Xiaochen Liu, et al.
ACS Nano|February 13, 2023
Multifunctional Microgel-Based Cream Hydrogels for Postoperative Abdominal Adhesion PreventionBo Liu, Yunfan Kong, Olawale A Alimi, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Oncotarget|May 8, 2015
Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesNaushad Ali, Parthasarathy Chandrakesan, Charles B Nguyen, et al.
Cancers|January 10, 2026
BRG1 (SMARCA4) Status Dictates the Response to EGFR Inhibitors in Wild-Type EGFR Non-Small Cell Lung CancerRebaz Ahmed, Ranganayaki Muralidharan, Narsireddy Amreddy, et al.
Plos One|November 22, 2013
Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanismNaushad Ali, Heba Allam, Ted Bader, et al.
International Journal of Cancer|March 27, 2018
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, et al.
Oncotarget|January 22, 2015
DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaNathaniel Weygant, Dongfeng Qu, Randal May, et al.
British Journal of Cancer|May 27, 2020
The role of sex in the innate and adaptive immune environment of metastatic colorectal cancerAnita L Ray, Robert A Nofchissey, Maaz A Khan, et al.
Pageof 5